Meyka Pro banner
Femasys Inc.

Femasys Inc. Fundamental Analysis (NASDAQ: FEMY)

FEMY●NASDAQ
HealthcareMedical - Instruments & Supplies
$1.24
$0.02(1.59%)
U.S. Market opens in 51h 34m

Femasys Inc. Fundamental Analysis (NASDAQ: FEMY)

Femasys Inc. (NASDAQ: FEMY) shows moderate financial fundamentals with a PE ratio of -0.31, profit margin of -6.41%, and ROE of -1.14%. The company generates $0.0B in annual revenue with strong year-over-year growth of 40.77%.

Key Strengths

Cash Position574.46%
PEG Ratio-0.00
Current Ratio8.67

Areas of Concern

ROE-1.14%
Operating Margin-9.30%
We analyze FEMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -554.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-554.7/100

We analyze FEMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FEMY struggles to generate sufficient returns from assets.

ROA > 10%
-36.07%

Valuation Score

Excellent

FEMY trades at attractive valuation levels.

PE < 25
-0.31
PEG Ratio < 2
-0.00

Growth Score

Excellent

FEMY delivers strong and consistent growth momentum.

Revenue Growth > 5%
40.77%
EPS Growth > 10%
44.05%

Financial Health Score

Excellent

FEMY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.18
Current Ratio > 1
8.67

Profitability Score

Weak

FEMY struggles to sustain strong margins.

ROE > 15%
-114.48%
Net Margin ≥ 15%
-6.41%
Positive Free Cash Flow
No

Key Financial Metrics

Is FEMY Expensive or Cheap?

P/E Ratio

FEMY trades at -0.31 times earnings. This suggests potential undervaluation.

-0.31

PEG Ratio

When adjusting for growth, FEMY's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Femasys Inc. at 0.15 times its book value. This may indicate undervaluation.

0.15

EV/EBITDA

Enterprise value stands at -2.84 times EBITDA. This is generally considered low.

-2.84

How Well Does FEMY Make Money?

Net Profit Margin

For every $100 in sales, Femasys Inc. keeps $-6.41 as profit after all expenses.

-6.41%

Operating Margin

Core operations generate -9.30 in profit for every $100 in revenue, before interest and taxes.

-9.30%

ROE

Management delivers $-1.14 in profit for every $100 of shareholder equity.

-1.14%

ROA

Femasys Inc. generates $-36.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-36.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Femasys Inc. generates limited operating cash flow of $-44.05M, signaling weaker underlying cash strength.

$-44.05M

Free Cash Flow

Femasys Inc. generates weak or negative free cash flow of $-44.68M, restricting financial flexibility.

$-44.68M

FCF Per Share

Each share generates $-5.16 in free cash annually.

$-5.16

FCF Yield

FEMY converts -1.61% of its market value into free cash.

-1.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.31

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.15

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.39

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.18

vs 25 benchmark

Current Ratio

Current assets to current liabilities

8.67

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.14

vs 25 benchmark

ROA

Return on assets percentage

-0.36

vs 25 benchmark

ROCE

Return on capital employed

-0.58

vs 25 benchmark

How FEMY Stacks Against Its Sector Peers

MetricFEMY ValueSector AveragePerformance
P/E Ratio-0.3130.24 Better (Cheaper)
ROE-114.48%540.00% Weak
Net Margin-640.89%-2322.00% (disorted) Weak
Debt/Equity0.180.08 Weak (High Leverage)
Current Ratio8.675.59 Strong Liquidity
ROA-36.07%-17516.00% (disorted) Weak

FEMY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Femasys Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-34.29%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

19.89%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-12.68%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ